Search > Thalassemia
My employer runs this trial

LISTEN App for Aphasia

(LISTEN Trial)

Not yet recruiting at 1 trial location
JR
Overseen ByJohn Rhee, MD, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Dana-Farber Cancer Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This is a feasibility and pilot study to refine and test LISTEN, an AI-based augmentative and alternative communication (AAC) smartphone app, integrated into the patient's personal electronic device, to augment and facilitate communication in patients with tumor-related aphasia (TRA) and their care partners. The study will assess the feasibility and acceptability of LISTEN in patients with TRA and their care partners.

Who Is on the Research Team?

JR

John Rhee, MD, MPH

Principal Investigator

Dana-Farber Cancer Institute

Are You a Good Fit for This Trial?

This trial is for people who have trouble speaking or understanding language (aphasia) due to a brain tumor. Participants should be able to use a smartphone and have a care partner willing to join the study.

Inclusion Criteria

Patient has mild-to-moderate aphasia or other acquired communication disorder as determined by their oncologist or speech-language pathologist
My care partner is 18 years old or older.
I am 18 years old or older.
See 9 more

Exclusion Criteria

I have severe problems with memory or thinking, as determined by my doctor.
Patient is unable to read or respond to questions in English
Care-partner is unable to read or respond to questions in English
See 3 more

What Are the Treatments Tested in This Trial?

Interventions

  • LISTEN (AI-based AAC smartphone app)

Trial Overview

The study is testing LISTEN, an AI-powered communication app on smartphones, designed to help patients with tumor-related aphasia communicate better. The focus is on seeing if using the app is practical and helpful.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Group I: Arm 3Experimental Treatment1 Intervention
Group II: Arm 2Experimental Treatment1 Intervention
Group III: Arm 1Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dana-Farber Cancer Institute

Lead Sponsor

Trials
1,128
Recruited
382,000+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.